Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
39.41
+0.04 (0.10%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Immunovant Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Reiterates $53 | Buy | Reiterates | $53 | +34.48% | Jul 9, 2026 |
| Citi | Citi | Buy Maintains $57 → $61 | Buy | Maintains | $57 → $61 | +54.78% | Jun 30, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $66 | Buy | Maintains | $66 | +67.47% | May 29, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $35 → $47 | Buy | Maintains | $35 → $47 | +19.26% | May 26, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $44 → $62 | Buy | Maintains | $44 → $62 | +57.32% | May 26, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $40 | Buy | Reiterates | $40 | +1.50% | May 26, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $49 | Buy | Maintains | $49 | +24.33% | May 25, 2026 |
| Truist Financial | Truist Financial | Hold Maintains $23 → $30 | Hold | Maintains | $23 → $30 | -23.88% | May 21, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.